• All the women in Citron's study received a cocktail of cancer drugs, including Bristol-Myers Squibb 's (nyse: BMY - news - people ) Taxol, Bristol-Myers' Cytoxan and Pharmacia 's (nyse: PHA - news - people ) Adriamycin, all of which are available in generic forms.

    FORBES: Magazine Article

  • Other competitors in the healthcare sector include: PDL BioPharma Inc. (PDLI), Abbott Laboratories (ABT), and Bristol Myers Squibb (BMY).

    FORBES: Earnings Preview: Alexion Pharmaceuticals, Inc.

  • The other, a similar compound called pravastatin sodium, is manufactured by Bristol-Myers Squibb bmy (nyse: bmy - news - people) under the brand name Pravachol.

    FORBES: FDA Rejects Over-The-Counter Cholesterol Drugs

  • The consortium is a who's who of important pharmaceutical names: AstraZeneca azn (nyse: azn - news - people), Bristol-Myers Squibb bmy (nyse: bmy - news - people), Glaxo Wellcome glx (nyse: glx - news - people), Novartis nvs (nyse: nvs - news - people), Pfizer pfe (nyse: pfe - news - people)and SmithKline Beecham sbh (nyse: sbh - news - people).

    FORBES: Orchid Biosciences Not Yet In The Black

  • Bristol-Myers Squibb (BMY) is expected to report poor fourth quarter earnings on Thursday, January 24, 2013 with analysts expecting a 18.9% drop in earnings from a year ago.

    FORBES: Earnings Preview: Bristol Myers Squibb

  • Among the largest underlying components of PJP, in trading today Prestige Brands Holdings ( PBH) is down about 0.7%, and Bristol Myers Squibb Company ( BMY) is up by about 0.2%.

    FORBES: Pharmaceuticals See Big Inflows

  • Prior to becoming chairman and CEO of Spectrum, Dr. Shrotriya was the Worldwide Executive Director for CNS (central nervous system) Clinical Research at Bristol Myers-Squibb (BMY), where he worked for 18 years.

    FORBES: Straightforward Talk From Spectrum Pharmaceuticals Helps Attract Investors

  • Bristol-Myers Squibb ( BMY) and Pfizer ( PFE) announced over the weekend positive results in a Phase 3 trial that compared Elquis to warfarin for the prevention of stroke or systemic embolism in patients with atrial fibrillation and at least one risk factor for stroke.

    FORBES: Bristol-Myers, Pfizer Announce Positive Results; An FDA Approval for Pfizer

  • In the past four years, AstraZeneca ( AZN), Pfizer ( PFE), Eli Lilly ( LLY), Bristol-Myers Squibb ( BMY) and Forest Labs ( FRX) have all settled federal charges of marketing psychoactive drugs off-label, at a cost running into hundreds of millions.

    FORBES: Bad Side-Effects Ahead For Pharma?

  • In recent years, its fastest-growing product has been a once-a-day HIV drug that combines a Gilead-produced medicine with one made by Bristol-Myers Squibb ( BMY), in an all-in-one treatment that represents a big advantage over the cocktail of individual drugs AIDS patients once were obliged to swallow.

    FORBES: Cash Rich But What's Gilead's Next Big Drug?

  • They include drug-maker Bristol-Myers Squibb (BMY), technology companies Cisco Systems (CSCO-Nasdaq) and Juniper Networks, capital goods firms Honeywell International (HON), First Solar (FSLR-Nasdaq), Masco (MAS), PACCAR (PCAR-Nasdaq), Eaton (ETN) and Emerson Electric (EMR), sneaker maker Nike (NKE), online retailer Priceline.com, energy company Baker Hughes and cosmetics concern Estee Lauder.

    FORBES: Sell America, Buy Europe (Selectively)

  • Bristol-Myers Squibb ( BMY - news - people ) under the Taxol name.

    FORBES: Patrick Soon-Shiong and one of cancer's biggest riddles.

  • Bristol-Myers Squibb ( BMY - news - people ) sells a drug called Sprycel that competes with Tasigna.

    FORBES: Pipelines

  • Bristol-Myers Squibb ( BMY - news - people ) has been collaborating with Medarex for years but now will get full rights to the drug.

    FORBES: Health Care

  • Bristol-Myers Squibb ( BMY - news - people ) moved slightly higher after a federal panel said the company's diabetes drug appears free from the kinds of heart problems seen with similar drugs.

    FORBES: This is a transcript of the After Hours video report.

  • Bristol-Myers Squibb ( BMY - news - people ), and Geodon, from Pfizer, both make similar claims, that could lead to "a modest niche" for Fanapt, says John Newcomer, a psychiatrist at Washington University in St.

    FORBES: Pharmaceuticals

  • Bristol-Myers Squibb ( BMY - news - people ) learned that the Food and Drug Administration is extending until July 30 (from April 30) the time it is taking to review their application for the Type 2 diabetes treatment, saxagliptin, also known by its commercial name, Onglyza.

    FORBES: Stock Of The Week

  • Bristol-Myers Squibb (59, BMY), whose shares have tumbled 20% since December, also faces problems with new generic competitors.

    FORBES: Drugs of Choice

  • Among the largest underlying components of HDV, in trading today ConocoPhillips ( NYSE: COP) is up about 0.3%, Altria Group Incorporated ( NYSE: MO) is up about 0.2%, and Bristol Myers Squibb Company ( NYSE: BMY) is lower by about 0.1%.

    FORBES: Juicy Dividends Lure Investors Back Into Equities

  • Among the largest underlying components of HDV, in trading today Intel Corporation ( NASD: INTC) is up about 0.4%, Altria Group Incorporated ( NYSE: MO) is up about 1.1%, and Bristol Myers Squibb Company ( NYSE: BMY) is higher by about 1.4%.

    FORBES: Investors Boost High Yield Dividend Holdings

  • Among the largest underlying components of PJP, in trading today Prestige Brands Holdings Incorporated ( NYSE: PBH) is up about 0.6%, Bristol Myers Squibb Company ( NYSE: BMY) is off about 0.9%, and The Medicines Company ( NASD: MDCO) is higher by about 0.3%.

    FORBES: Noteworthy ETF Outflows: PJP, PBH, BMY, MDCO

  • Among the largest underlying components of OEF, in trading today Occidental Petroleum Corporation ( NYSE: OXY) is up about 0.9%, Bank of America Corporation ( NYSE: BAC) is down about 0.7%, and Bristol Myers Squibb Company ( NYSE: BMY) is higher by about 1.4%.

    FORBES: OEF, OXY, BAC, BMY: Large Outflows Detected at ETF

  • Bristol-Myers Squibb (nyse: BMY - news - people ) and GlaxoSmithkline are testing similar drugs.

    FORBES: Fat City

  • Pravachol, a Bristol-Myers Squibb (nyse: BMY - news - people) drug, takes most of the leftovers.

    FORBES: Magazine Article

  • Pravachol, made by Bristol-Myers Squibb (nyse: BMY - news - people ), is the next biggest.

    FORBES: Magazine Article

  • Barrow dumps stocks when they get too expensive, as Bristol-Myers Squibb (nyse: BMY - news - people) did.

    FORBES: Keep the Faith

  • Pargluva, from Bristol-Myers Squibb (nyse: BMY - news - people ), was never approved after such an analysis.

    FORBES: Open-Source Drug Safety?

  • Sanofi now sells Ambien on its own, but Bristol-Myers Squibb (nyse: BMY - news - people ) markets Plavix.

    FORBES: Pfizer's New Foe

  • Bristol-Myers Squibb (nyse: BMY - news - people) has gotten rid of both its orthopedics and beauty products divisions.

    FORBES: Magazine Article

  • And a committee recommended approval for Pargluva, a diabetes drug from Bristol-Myers Squibb (nyse: BMY - news - people ).

    FORBES: The Danger In Dendreon

$firstVoiceSent
- 来自原声例句
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定
小调查
请问您想要如何调整此模块?

感谢您的反馈,我们会尽快进行适当修改!
进来说说原因吧 确定